Cargando…
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives
Mitochondrial targeting is a promising approach for solving current issues in clinical application of chemotherapy and diagnosis of several disorders. Here, we discuss direct conjugation of mitochondrial-targeting moieties to anticancer drugs, antioxidants and sensor molecules. Among them, the most...
Autores principales: | Battogtokh, Gantumur, Choi, Yeon Su, Kang, Dong Seop, Park, Sang Jun, Shim, Min Suk, Huh, Kang Moo, Cho, Yong-Yeon, Lee, Joo Young, Lee, Hye Suk, Kang, Han Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251809/ https://www.ncbi.nlm.nih.gov/pubmed/30505656 http://dx.doi.org/10.1016/j.apsb.2018.05.006 |
Ejemplares similares
-
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
por: Obidiro, Onyinyechi, et al.
Publicado: (2023) -
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases
por: Seok, Jin Kyung, et al.
Publicado: (2023) -
pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation
por: Kim, Chang Hyun, et al.
Publicado: (2018) -
In-vitro cytotoxicity assessment of carbon-nanodot-conjugated Fe-aminoclay (CD-FeAC) and its bio-imaging applications
por: Kang, Kyoung Suk, et al.
Publicado: (2015)